<DOC>
	<DOCNO>NCT01132547</DOCNO>
	<brief_summary>RATIONALE : Cyproheptadine hydrochloride may prevent weight loss cause cancer cancer treatment . It yet know whether cyproheptadine effective placebo prevent weight loss young patient receive chemotherapy cancer . PURPOSE : This randomized phase III trial study cyproheptadine hydrochloride see well work prevent weight loss young patient receive chemotherapy cancer .</brief_summary>
	<brief_title>Cyproheptadine Preventing Weight Loss Children Receiving Chemotherapy Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - To determine effect cyproheptadine hydrochloride prevention cancer- treatment-related weight loss ( define ≥ 5 % reduction weight baseline measurement ) child initiate course moderately highly emetic chemotherapy . Secondary - To investigate effect cyproheptadine HCl change weight age score 8 week study drug administration comparison placebo . - Investigate relationship secondary outcome variable ( prealbumin , triceps skin fold , mid-upper arm circumference , weight loss ) baseline end treatment group ( treatment placebo ) separately . OUTLINE : This multicenter study . Patients stratify accord enrol center steroid use cancer treatment ( yes v ) . Study agent start anytime include day 28 first dose chemotherapy . - Arm I : Patients receive oral cyproheptadine hydrochloride twice daily 8 week . - Arm II : Patients receive oral placebo twice daily 8 week . Patients undergo weight height measurement baseline follow-up visit week 4 8 evaluate effect cyproheptadine hydrochloride duration response . Patients parent complete medicine log follow-up visit week 4 8 evaluate drug compliance tolerance . Patients also undergo measure nutrition ; measure body composition , lean body mass , fat percentage use standardized equipment procedure measure triceps skin fold mid-arm muscle circumference baseline end study . Patients undergo blood sample collection baseline end study biomarker study . Samples analyze pre-albumin level .</detailed_description>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Cyproheptadine</mesh_term>
	<criteria>INCLUSION CRITERIA : ≥ 2 year ≤ 21 year age time study entry Scheduled receive chemotherapy : Newly diagnose : Nonrhabdo soft tissue sarcoma , schedule receive chemotherapy , well intermediate highrisk rhabdomyosarcoma , stage osteosarcoma stage Ewing 's sarcoma Intermediate highrisk neuroblastoma Wilms ' tumor ( Stage III/IV ) Hepatoblastoma ( Stage III/IV ) Germ cell tumor ( Stage III/IV ) Brain tumor , include medulloblastoma , PNET ependymomas AML Relapsed/recurrent disease ( patient ) Able register randomize within 28 day start chemotherapy ( registration /randomization start study agent may occur anytime include Day 28 initiation chemotherapy ) EXCLUSION CRITERIA : ≥ 29 day start chemotherapy Documented history unintended weight loss ≥ 5 % presumed secondary cancer within 3 month study entry Currently take cyproheptadine HCl ( take cyproheptadine HCl within 3 week study registration ) History anorexia nervosa bulimia Taking appetitestimulating medication , i.e . dronabinol ( Marinol ) past three week . Initiation appetite enhance agent , include steroid prescribe intent weight gain , i.e . Megace . Note : Other form nutrition therapy , e.g . appetitestimulating medication , TPN enteral tube feeding allow study . Children receive steroid &gt; 7 day part cancer treatment regimen exclude participation . However , intermittent steroid use antiemetic regimen allow study Receiving monoamine oxidase ( MAO ) inhibitor , procarbazine , fluoxetine ( Prozac ) , paroxetine ( Paxil ) Diagnosed glaucoma , cystic fibrosis , inflammatory bowel disease , GI/GU obstruction Allergy cyproheptadine HCl Females childbearing age must pregnant . Female patient lactate must agree stop breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>cachexia</keyword>
	<keyword>weight change</keyword>
	<keyword>nausea vomit</keyword>
	<keyword>alveolar childhood rhabdomyosarcoma</keyword>
	<keyword>anaplastic osteosarcoma</keyword>
	<keyword>childhood alveolar soft-part sarcoma</keyword>
	<keyword>childhood angiosarcoma</keyword>
	<keyword>childhood epithelioid sarcoma</keyword>
	<keyword>childhood fibrosarcoma</keyword>
	<keyword>childhood gliosarcoma</keyword>
	<keyword>childhood leiomyosarcoma</keyword>
	<keyword>childhood liposarcoma</keyword>
	<keyword>childhood neurofibrosarcoma</keyword>
	<keyword>childhood synovial sarcoma</keyword>
	<keyword>chondrosarcoma</keyword>
	<keyword>chondrosarcomatous osteosarcoma</keyword>
	<keyword>clear cell sarcoma kidney</keyword>
	<keyword>embryonal childhood rhabdomyosarcoma</keyword>
	<keyword>embryonal-botryoid childhood rhabdomyosarcoma</keyword>
	<keyword>endometrial stromal sarcoma</keyword>
	<keyword>extraosseous Ewing sarcoma</keyword>
	<keyword>peripheral primitive neuroectodermal tumor</keyword>
	<keyword>fibrosarcomatous osteosarcoma</keyword>
	<keyword>localize Ewing sarcoma</keyword>
	<keyword>localize osteosarcoma</keyword>
	<keyword>mast cell sarcoma</keyword>
	<keyword>metastatic childhood soft tissue sarcoma</keyword>
	<keyword>metastatic Ewing sarcoma</keyword>
	<keyword>metastatic osteosarcoma</keyword>
	<keyword>mixed childhood rhabdomyosarcoma</keyword>
	<keyword>mixed osteosarcoma</keyword>
	<keyword>nonmetastatic childhood soft tissue sarcoma</keyword>
	<keyword>osteoblastic osteosarcoma</keyword>
	<keyword>ovarian carcinosarcoma</keyword>
	<keyword>ovarian sarcoma</keyword>
	<keyword>pleomorphic childhood rhabdomyosarcoma</keyword>
	<keyword>previously treat childhood rhabdomyosarcoma</keyword>
	<keyword>previously untreated childhood rhabdomyosarcoma</keyword>
	<keyword>recurrent adult soft tissue sarcoma</keyword>
	<keyword>recurrent childhood gliosarcoma</keyword>
	<keyword>recurrent childhood rhabdomyosarcoma</keyword>
	<keyword>recurrent childhood soft tissue sarcoma</keyword>
	<keyword>recurrent Ewing sarcoma</keyword>
	<keyword>recurrent osteosarcoma</keyword>
	<keyword>recurrent uterine sarcoma</keyword>
	<keyword>small intestine leiomyosarcoma</keyword>
	<keyword>stage I uterine sarcoma</keyword>
	<keyword>stage II uterine sarcoma</keyword>
	<keyword>stage III uterine sarcoma</keyword>
	<keyword>stage IV uterine sarcoma</keyword>
	<keyword>telangiectatic osteosarcoma</keyword>
	<keyword>untreated childhood gliosarcoma</keyword>
	<keyword>uterine carcinosarcoma</keyword>
	<keyword>uterine leiomyosarcoma</keyword>
	<keyword>localize resectable neuroblastoma</keyword>
	<keyword>localize unresectable neuroblastoma</keyword>
	<keyword>recurrent neuroblastoma</keyword>
	<keyword>regional neuroblastoma</keyword>
	<keyword>stage 4S neuroblastoma</keyword>
	<keyword>recurrent Wilms tumor</keyword>
	<keyword>childhood kidney tumor</keyword>
	<keyword>stage III Wilms tumor</keyword>
	<keyword>stage IV Wilms tumor</keyword>
	<keyword>childhood hepatoblastoma</keyword>
	<keyword>childhood extracranial germ cell tumor</keyword>
	<keyword>childhood extragonadal germ cell tumor</keyword>
	<keyword>childhood gonadal germ cell tumor</keyword>
	<keyword>childhood malignant ovarian germ cell tumor</keyword>
	<keyword>childhood malignant testicular germ cell tumor</keyword>
	<keyword>recurrent childhood malignant germ cell tumor</keyword>
	<keyword>recurrent extragonadal germ cell tumor</keyword>
	<keyword>recurrent extragonadal non-seminomatous germ cell tumor</keyword>
	<keyword>recurrent malignant testicular germ cell tumor</keyword>
	<keyword>recurrent ovarian germ cell tumor</keyword>
	<keyword>stage III extragonadal non-seminomatous germ cell tumor</keyword>
	<keyword>stage III malignant testicular germ cell tumor</keyword>
	<keyword>stage IIIA ovarian germ cell tumor</keyword>
	<keyword>stage IIIB ovarian germ cell tumor</keyword>
	<keyword>stage IIIC ovarian germ cell tumor</keyword>
	<keyword>stage IV extragonadal non-seminomatous germ cell tumor</keyword>
	<keyword>stage IV ovarian germ cell tumor</keyword>
	<keyword>recurrent childhood medulloblastoma</keyword>
	<keyword>untreated childhood medulloblastoma</keyword>
	<keyword>childhood ependymoblastoma</keyword>
	<keyword>childhood infratentorial ependymoma</keyword>
	<keyword>newly diagnose childhood ependymoma</keyword>
	<keyword>recurrent childhood ependymoma</keyword>
	<keyword>recurrent childhood subependymal giant cell astrocytoma</keyword>
	<keyword>untreated childhood subependymal giant cell astrocytoma</keyword>
	<keyword>peripheral primitive neuroectodermal tumor kidney</keyword>
	<keyword>childhood supratentorial primitive neuroectodermal tumor</keyword>
	<keyword>recurrent childhood brain stem glioma</keyword>
	<keyword>recurrent childhood brain tumor</keyword>
	<keyword>untreated childhood brain stem glioma</keyword>
	<keyword>recurrent childhood anaplastic astrocytoma</keyword>
	<keyword>recurrent childhood anaplastic oligoastrocytoma</keyword>
	<keyword>recurrent childhood anaplastic oligodendroglioma</keyword>
	<keyword>stage I childhood anaplastic large cell lymphoma</keyword>
	<keyword>stage II childhood anaplastic large cell lymphoma</keyword>
	<keyword>stage III childhood anaplastic large cell lymphoma</keyword>
	<keyword>stage IV childhood anaplastic large cell lymphoma</keyword>
	<keyword>untreated childhood anaplastic astrocytoma</keyword>
	<keyword>untreated childhood anaplastic oligoastrocytoma</keyword>
	<keyword>untreated childhood anaplastic oligodendroglioma</keyword>
	<keyword>childhood high-grade cerebellar astrocytoma</keyword>
	<keyword>childhood low-grade cerebellar astrocytoma</keyword>
	<keyword>recurrent childhood astrocytoma</keyword>
	<keyword>tumor glial origin</keyword>
	<keyword>recurrent childhood cerebellar astrocytoma</keyword>
	<keyword>recurrent childhood cerebral astrocytoma</keyword>
	<keyword>recurrent childhood diffuse astrocytoma</keyword>
	<keyword>recurrent childhood fibrillary astrocytoma</keyword>
	<keyword>recurrent childhood gemistocytic astrocytoma</keyword>
	<keyword>recurrent childhood oligoastrocytoma</keyword>
	<keyword>recurrent childhood pilocytic astrocytoma</keyword>
	<keyword>recurrent childhood pilomyxoid astrocytoma</keyword>
	<keyword>recurrent childhood pleomorphic xanthoastrocytoma</keyword>
	<keyword>recurrent childhood protoplasmic astrocytoma</keyword>
	<keyword>untreated childhood cerebellar astrocytoma</keyword>
	<keyword>untreated childhood cerebral astrocytoma</keyword>
	<keyword>untreated childhood diffuse astrocytoma</keyword>
	<keyword>untreated childhood fibrillary astrocytoma</keyword>
	<keyword>untreated childhood gemistocytic astrocytoma</keyword>
	<keyword>untreated childhood oligoastrocytoma</keyword>
	<keyword>untreated childhood pilocytic astrocytoma</keyword>
	<keyword>untreated childhood pilomyxoid astrocytoma</keyword>
	<keyword>untreated childhood pleomorphic xanthoastrocytoma</keyword>
	<keyword>untreated childhood protoplasmic astrocytoma</keyword>
	<keyword>recurrent childhood gliomatosis cerebri</keyword>
	<keyword>recurrent childhood oligodendroglioma</keyword>
	<keyword>recurrent childhood visual pathway</keyword>
	<keyword>hypothalamic glioma</keyword>
	<keyword>recurrent childhood visual pathway glioma</keyword>
	<keyword>untreated childhood gliomatosis cerebri</keyword>
	<keyword>untreated childhood oligodendroglioma</keyword>
	<keyword>untreated childhood visual pathway</keyword>
	<keyword>untreated childhood visual pathway glioma</keyword>
	<keyword>recurrent childhood giant cell glioblastoma</keyword>
	<keyword>recurrent childhood glioblastoma</keyword>
	<keyword>untreated childhood giant cell glioblastoma</keyword>
	<keyword>untreated childhood glioblastoma</keyword>
	<keyword>childhood choroid plexus tumor</keyword>
	<keyword>childhood grade I meningioma</keyword>
	<keyword>childhood grade II meningioma</keyword>
	<keyword>childhood grade III meningioma</keyword>
	<keyword>minimally differentiate myeloid leukemia ( M0 )</keyword>
	<keyword>myeloblastic leukemia maturation ( M2 )</keyword>
	<keyword>myeloblastic leukemia without maturation ( M1 )</keyword>
	<keyword>childhood acute myelomonocytic leukemia ( M4 )</keyword>
	<keyword>childhood acute promyelocytic leukemia ( M3 )</keyword>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
	<keyword>untreated childhood acute myeloid leukemia</keyword>
	<keyword>myeloid malignancy</keyword>
	<keyword>childhood acute monoblastic leukemia ( M5a )</keyword>
	<keyword>childhood acute monocytic leukemia ( M5b )</keyword>
	<keyword>childhood acute erythroleukemia ( M6 )</keyword>
	<keyword>childhood acute megakaryocytic leukemia ( M7 )</keyword>
	<keyword>unspecified childhood solid tumor</keyword>
</DOC>